AllianceBernstein (AB) upgraded to Buy: private wealth upside, strong margins, and 2026 macro tailwinds—plus dividend ...

Bitcoin is rated 'Strong Buy' due to robust network value, user growth, and an attractive current entry point. Read what ...

In some ways, data and its quality can seem strange to people used to assessing the quality of software. There’s often no observable behaviour to check and little in the way of structure to help you ...

Dogecoin DOGE and Shiba Inu SHIB have both fallen roughly 13% over the past week, but on-chain activity and technical signals ...

As enterprises pour billions into GPU infrastructure for AI workloads, many are discovering that their expensive compute resources sit idle far more than expected. The culprit isn't the hardware. It’s ...

Chromosomes are masters of organization. These long strings of DNA fold down into an ensemble of compact structures that keep needed parts of the genome accessible while tucking away those that aren't ...

The 2024 Nobel Prize in Chemistry was recently granted to David Baker, Demis Hassabis and John M. Jumper, renowned for their pioneering works in protein design. In addition, Nature has recently ...

Abstract: Graph neural networks (GNNs), as a cutting-edge technology in deep learning, perform particularly well in various tasks that process graph structure data. However, their foundation on ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Graphs are everywhere. From technology to finance, they often model valuable information such as people, networks, biological pathways and more. Often, scientists and technologists need to come up ...